Quent Capital, LLC Sarepta Therapeutics, Inc. Transaction History
Quent Capital, LLC
- $882 Million
- Q2 2024
A detailed history of Quent Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 16 shares of SRPT stock, worth $2,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 13
23.08%
Holding current value
$2,295
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SRPT
# of Institutions
559Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.48 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.3 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$620 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$594 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$547 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $12.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...